Allergan and DMRF Continue Longstanding Partnership

New Survey to Determine Awareness and Impact of Cervical Dystonia on Patients and Families

10/10/16

Allergan and the DMRF are proud to continue a long-standing partnership in support of dystonia patients by conducting a survey to evaluate awareness of cervical dystonia, its symptoms, and treatment options in order to encourage education and proper diagnosis of this often-disabling condition. Details about the survey and instructions will be available at dystonia-foundation.org.

“Our partnership with Allergan on this survey will support patients with cervical dystonia and their families by shedding light on the lack of awareness of the condition,” said Art Kessler, DMRF President. “It is imperative that patients have accurate information about cervical dystonia in order to seek the appropriate care and treatment options. Equally as critical is continuing to work with a healthcare provider.”

“Allergan is committed to supporting patients with cervical dystonia and educating the public about this condition in order to encourage proper diagnosis and treatment,” said Mitchell Brin, MD, Senior Vice President Global Drug Development and Chief Scientific Officer, Botox®. “We value our continued partnership with the DMRF to raise awareness of cervical dystonia, potential treatment options and the importance of talking to your doctor.”

DMRF’s partnership with Allergan has also included raising awareness through Dystonia Zoo Walks in cities across the United States.

Accelerating Research & Inspiring Hope

The Dystonia Medical Research Foundation (DMRF) has served the dystonia community since 1976. Join us in our global effort to find a cure.